0.6788
-0.0321 (-4.52%)
-0.0321 (-4.52%)
Upgrade to Real-Time
Afterhours (Closed)
| Volume | 331,140 |
|
|||||
| News | - | ||||||
| Day High | 0.708 | Low High |
|||||
| Day Low | 0.66 | ||||||
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| CNS Pharmaceuticals Inc | CNSP | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
 |
|
|---|---|---|---|---|
| -0.0321 | -4.52% | 0.6788 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.708 | 0.66 | 0.708 | 0.6655 | 0.7109 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,126 | 331,140 | $ 0.6685367 | $ 221,379 | - | 0.66 - 4.46 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:46:02 | 2 | $ 0.63 | USD |
Period:
Draw Mode:
CNS Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 18.95M | 27.92M | 17.56M | $ - | $ - | -0.57 | -1.20 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 14.50k | 3.80% |
CNS Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CNSP Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.72 | 0.7964 | 0.66 | 0.7429046 | 294,142 | -0.0412 | -5.72% |
| 1 Month | 0.8603 | 1.38 | 0.66 | 0.9644545 | 1,919,838 | -0.1815 | -21.1% |
| 3 Months | 1.38 | 1.48 | 0.66 | 1.01 | 785,507 | -0.7012 | -50.81% |
| 6 Months | 1.82 | 1.85 | 0.66 | 1.11 | 424,793 | -1.14 | -62.7% |
| 1 Year | 2.02 | 4.46 | 0.66 | 2.31 | 704,143 | -1.34 | -66.4% |
| 3 Years | 4.11 | 5.6899 | 0.66 | 2.43 | 533,080 | -3.43 | -83.48% |
| 5 Years | 4.11 | 5.6899 | 0.66 | 2.43 | 533,080 | -3.43 | -83.48% |
CNS Pharmaceuticals Description
| CNS Pharmaceuticals Inc is a preclinical stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. |